Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03465371 · ClinicalTrials.gov registry record · NA

CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated Specialty Care

A NA study of Psychosis, sponsored by Center for Social Innovation, Massachusetts.

Completed
Registry status
NA
Development phase
349
Enrollment target
1
Study location

NCT03465371: Completed NA study of Psychosis, sponsored by Center for Social Innovation, Massachusetts.

NCT03465371 is a NA study of Psychosis that has completed, run by Center for Social Innovation, Massachusetts. The registered enrollment target is 349 participants, above the 169-participant average among 35 other Psychosis trials with a reported enrollment target (107% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03465371, a NA study of Psychosis, has completed, sponsored by Center for Social Innovation, Massachusetts.

COMPLETED
Registry status
NA
Development phase
349 participants
Enrollment target
1
Study location

Study Summary

In response to the growing need for training on interventions to address first episode psychosis, the Center for Social Innovation (C4) partnered with experts in Coordinated Specialty Care (CSC) to develop and test CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated Specialty Care. The product builds on the findings of the Recovery After an Initial Schizophrenia Episode (RAISE) studies, funded by the National Institute of Mental Health (NIMH). RAISE examined team-based models of care for people early in the course of schizophrenia. Through a Fast Track Small Business Innovation Research (SBIR) grant, investigators will prototype, test, refine, and evaluate the impact of CSC OnDemand.

Primary Outcome

CSC knowledge will be assessed with a 50-item, complex, multiple-choice test (25 common across disciplines, 25 discipline-specific), which will be created in conjunction with the intervention modules and will be piloted in Phase I. The outcome will be the percentage of correct responses.

Conditions Studied

Interventions

  • OTHER CSC OnDemand Training Intervention
  • OTHER InPerson Intervention
  • OTHER Virtual InPerson Intervention

Study Locations (1)

Massachusetts

  • Center for Social Innovation - Needham

Trial Details

FieldValue
Enrollment Target 349 participants
Start Date 2018-10-01
Est. Completion 2022-01-31
Phase NA

What the finished NCT03465371 record still lists

NCT03465371 is an interventional study that assigns participants to a tested intervention. The registered 349 participants enrollment target is mid-sized for trials with a published cap, above the 169-participant average among 35 other Psychosis trials with a reported enrollment target (107% higher).

The record links to 1 condition, with Psychosis appearing as the primary indexed condition, and to 3 interventions - of which CSC OnDemand Training Intervention is the first listed.

NCT03465371 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03465371 about?

NCT03465371 is a clinical study titled "CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated Specialty Care". In response to the growing need for training on interventions to address first episode psychosis, the Center for Social Innovation (C4) partnered with experts in Coordinated Specialty Care (CSC) to develop and test CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated Spe...

What is the current status of trial NCT03465371?

This trial is currently completed. It is a NA study. The enrollment target is 349 participants. The study started on 2018-10-01. Estimated completion is 2022-01-31.

What conditions does trial NCT03465371 study?

This clinical trial studies the following conditions: Psychosis.

What interventions are being tested in trial NCT03465371?

The interventions under investigation include: CSC OnDemand Training Intervention (OTHER), InPerson Intervention (OTHER), Virtual InPerson Intervention (OTHER).

Who is sponsoring clinical trial NCT03465371?

This trial is sponsored by Center for Social Innovation, Massachusetts, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03465371 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Psychosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03465371's enrollment target sits among peer trials

349 4th of 35 higher than 32 of 35 other Psychosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Psychosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00900575 · 350 participants · NA

    Cervical Cancer Detection Using Optical Spectroscopy

  • NCT01627821 · 350 participants · NA

    Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study

  • NCT02357654 · 350 participants · Phase 4

    GnRH for Luteal Support in IVF/ICSI/FET Cycles

  • NCT03997370 · 350 participants · Phase 1

    Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03465371, the US trial registry maintained by the National Library of Medicine. NCT03465371 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.